Compare Apple Inc (AAPL) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Apple Inc vs DENTSPLY SIRONA Inc — how do they compare? Apple Inc trades at $312.07 (market cap $4.56T), while DENTSPLY SIRONA Inc trades at $11.6 (market cap $2.44B). The key difference: Apple Inc is far larger — about 1868.9× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals.
| AAPL | XRAY | |
|---|---|---|
Market Cap | $4.56T | $2.44B |
Volume | 100,358,844 | — |
Sector | Technology | Health |
52-Week High | $315.20 | $16.85 |
52-Week Low | $202.38 | $9.64 |
Enterprise Value | $4.58T | $4.58B |
Dividend Yield | 0.35% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Apple (AAPL) trades at $310.09, down 0.82% on the day, with a bullish technical signal from moving averages and strong institutional support. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $2.01 exceeding the $1.95 estimate. Revenue for 2025 reached $416.16 billion, driving a net income margin of 26.91%. Analysts maintain a consensus buy rating with a $329.62 price target, citing Apple's massive device base as an AI opportunity.
The outlook remains positive given earnings momentum and a $0.27 dividend, but risks include potential Q2 2026 earnings miss concerns and union disputes. Valuation multiples like P/E of 37.61 suggest premium pricing, requiring sustained growth to justify upside. Institutional holdings show mixed activity, with some trimming positions amid high RSI levels indicating overbought conditions near-term.
XRAY trades at $12.19, up 4.64% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q1 2026 EPS of $0.27, missing estimates of $0.28, continuing a trend of earnings misses. Revenue declined to $3.68B in 2025 with a net loss of $598M, though gross margin remains healthy at 48.93%. Recent news highlights distribution expansions and AI-enabled product launches, supporting growth initiatives amid ongoing profitability challenges.
The outlook remains mixed: analyst consensus is a 'Hold' with a $12.50 price target, near current levels. Upside potential exists from digital dentistry adoption and cost controls, but risks include persistent net losses, high debt-to-asset ratio of 42.88%, and competitive pressures. Investors should weigh stabilization efforts against margin headwinds and macroeconomic softness in European markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apple Inc
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
